In this paper, we report the synthesis of three new 2-aminoimidazoline (compounds 4b, 5b, and 6b) and three new guanidine derivatives (compounds 7b, 8b, and 9b) as potential alpha(2)-adrenoceptor antagonists for the treatment of depression. Their pharmacological profile was evaluated in vitro in human brain tissue and compared to the potential antidepressant 1 and the agonists 2 and 3. All new substrates were evaluated by in vitro functional [(35)S]GTPgammaS binding assays in human prefrontal cortex to determine their agonistic or antagonistic activity. Compound 8b was found to be an antagonist in vitro and was subjected to in vivo microdialysis experiments in rats. Moreover, a new synthesis of the precursor amines for compounds 4b-9b is presented.

Download full-text PDF

Source
http://dx.doi.org/10.1021/jm800838rDOI Listing

Publication Analysis

Top Keywords

evaluated vitro
8
guanidine 2-aminoimidazoline
4
2-aminoimidazoline aromatic
4
aromatic derivatives
4
derivatives alpha2-adrenoceptor
4
alpha2-adrenoceptor ligands
4
ligands searching
4
searching structure-activity
4
structure-activity relationships
4
relationships paper
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!